Rosalía Navarro-Pérez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rosalía Navarro-Pérez has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Ane Abad-Motos
Hospital Universitario Donostia, San Sebastian, Spain
2 shared publications - Javier Ripollés-Melchor
Department of Anaesthesiology, Hospital Universitario Infanta Leonor, Madrid, Spain
2 shared publications - Rachel Budithi
Department of Anaesthesiology, Froedtert Hospital Medical College of Wisconsin, Milwaukee, USA
2 shared publications - Ángel V. Espinosa
Fluid Therapy and Hemodynamic Monitoring Group of the Spanish Society of Anaesthesiology and Reanimation (SEDAR), Madrid, Spain
2 shared publications A. Abad-Gurumeta
Department of Anesthesiology, Hospital Universitario Infanta Leonor, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain
1 shared publicationA. Casasempere Sanus
Department of Anesthesiology, University Hospital of Manises, Valencia, Spain
1 shared publication
Latest Publications
- 11 October 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (10) , e70355
Postoperative Vasoactive Exposure Patterns and Outcomes After Non‐Cardiac Surgery: A Prespecified Analysis of the SQUEEZE Cohort
Background: Postoperative vasoactive therapy is usually summarised by its presence or duration, although haemodynamic support evolves over time. We investigated whether reproducible postoperative vasoactive exposure patterns provide prognostic information beyond the duration of postoperative vasoactive therapy. Methods: We performed a prespecified substudy of the international SQUEEZE cohort. Adults receiving postoperative vasoactive infusion within seven postoperative days after non‐cardiac surgery were included. Unsupervised k‐means clustering identified exposure patterns using duration of postoperative vasoactive infusion, cumulative vasoactive agent‐days, and peak number of concurrent agents. Associations with 30‐day mortality, acute kidney injury (AKI), and hospital length of stay were assessed using multivariable regression. A prespecified landmark analysis evaluated early postoperative vasoactive exposure burden during postoperative days 0–1. Results: Among 25,672 patients, 6676 (26.0%) received postoperative vasoactive infusion. Four reproducible exposure patterns were identified. Adjusted 30‐day mortality ranged from 9.7% in the low‐burden pattern to 35.3% in the high‐burden pattern but was not strictly monotonic, whereas adjusted AKI risk increased from 28.0% to 56.0% across patterns. In covariate‐adjusted models fitted to the same complete‐case cohort, discrimination was higher when exposure pattern rather than duration was included (AUC 0.818 vs. 0.795), while adding duration to pattern classification resulted in little additional discrimination (AUC 0.819). Findings were consistent in the early postoperative landmark analysis. Conclusions: Postoperative vasoactive exposure follows reproducible patterns characterised by persistence and overall treatment burden rather than binary classification alone. These patterns were associated with mortality, AKI, and hospital length of stay, and provided prognostic information beyond duration alone. Editorial Comment: This substudy and analysis of the SQUEEZE cohort, which represents a large sample of cases with focus on post‐operative vasopressor treatments, shows that more intensive vasopressor therapy was associated with worse postoperative outcomes, including for mortality and 30 days and postoperative acute kidney injury occurrence. Trial Registration: ClinicalTrials.gov identifier: NCT03805230
- 11 October 2026
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 70 (10) , e70355
Postoperative Vasoactive Exposure Patterns and Outcomes After Non‐Cardiac Surgery: A Prespecified Analysis of the SQUEEZE Cohort
Background: Postoperative vasoactive therapy is usually summarised by its presence or duration, although haemodynamic support evolves over time. We investigated whether reproducible postoperative vasoactive exposure patterns provide prognostic information beyond the duration of postoperative vasoactive therapy. Methods: We performed a prespecified substudy of the international SQUEEZE cohort. Adults receiving postoperative vasoactive infusion within seven postoperative days after non‐cardiac surgery were included. Unsupervised k‐means clustering identified exposure patterns using duration of postoperative vasoactive infusion, cumulative vasoactive agent‐days, and peak number of concurrent agents. Associations with 30‐day mortality, acute kidney injury (AKI), and hospital length of stay were assessed using multivariable regression. A prespecified landmark analysis evaluated early postoperative vasoactive exposure burden during postoperative days 0–1. Results: Among 25,672 patients, 6676 (26.0%) received postoperative vasoactive infusion. Four reproducible exposure patterns were identified. Adjusted 30‐day mortality ranged from 9.7% in the low‐burden pattern to 35.3% in the high‐burden pattern but was not strictly monotonic, whereas adjusted AKI risk increased from 28.0% to 56.0% across patterns. In covariate‐adjusted models fitted to the same complete‐case cohort, discrimination was higher when exposure pattern rather than duration was included (AUC 0.818 vs. 0.795), while adding duration to pattern classification resulted in little additional discrimination (AUC 0.819). Findings were consistent in the early postoperative landmark analysis. Conclusions: Postoperative vasoactive exposure follows reproducible patterns characterised by persistence and overall treatment burden rather than binary classification alone. These patterns were associated with mortality, AKI, and hospital length of stay, and provided prognostic information beyond duration alone. Editorial Comment: This substudy and analysis of the SQUEEZE cohort, which represents a large sample of cases with focus on post‐operative vasopressor treatments, shows that more intensive vasopressor therapy was associated with worse postoperative outcomes, including for mortality and 30 days and postoperative acute kidney injury occurrence. Trial Registration: ClinicalTrials.gov identifier: NCT03805230
- 2 September 2026
- Published by Wiley in World Journal of Surgery
- Vol. 50 (10) , 2838-2847
Perioperative Hemoglobin Trajectory and Hemoglobin Decrease in Major Abdominal Surgery
Background: Most studies evaluate perioperative hemoglobin at a single time point despite substantial changes across the perioperative period. We examined whether perioperative hemoglobin trajectory and perioperative hemoglobin decrease were associated with postoperative outcomes after major abdominal surgery. Methods: We performed a secondary analysis of the international POSTVenTT cohort, a prospective multicentre observational study of adults undergoing major abdominal surgery. Hemoglobin trajectory was defined according to anemia status preoperatively and at hospital discharge. Perioperative hemoglobin decrease was defined as the difference between preoperative and discharge hemoglobin concentration. Mixed‐effects logistic regression models adjusted for predefined clinical covariates and center clustering were used to evaluate associations with postoperative complications, postoperative transfusion, and 30‐day readmission. Results: Among 5302 patients, 3735 had both preoperative and discharge hemoglobin measurements and were included in trajectory analyses. Compared with patients without perioperative anemia, persistent anemia was associated with the higher odds of postoperative complications, postoperative transfusion, and 30‐day readmission, whereas new postoperative anemia showed similar but smaller associations. Greater perioperative hemoglobin decrease was associated with higher odds of postoperative complications. For each 10 g/L decrease, the odds of any postoperative complication increased by 35% (OR 1.35, 95% CI 1.26–1.45) and major complication by 49% (OR 1.49, 1.35–1.64). Associations persisted after accounting for transfusion exposure and baseline hemoglobin. Conclusions: Perioperative hemoglobin trajectory and perioperative hemoglobin decrease were associated with postoperative complications and 30‐day readmission after major abdominal surgery. Greater hemoglobin decrease remained associated with adverse outcomes after accounting for transfusion exposure and baseline hemoglobin. Trial Registration: The POSTVenTT study was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12621001517864; 8 November 2021). The trial protocol was approved by the South Metropolitan Health Service (Western Australia) Health Research Ethics Committee (EC00265), the Western Australia Research Governance System (RCG 4477), with local ethics and governance confirmed at each site before patient recruitment
- 2 September 2026
- Published by Wiley in World Journal of Surgery
- Vol. 50 (10) , 2838-2847
Perioperative Hemoglobin Trajectory and Hemoglobin Decrease in Major Abdominal Surgery
Background: Most studies evaluate perioperative hemoglobin at a single time point despite substantial changes across the perioperative period. We examined whether perioperative hemoglobin trajectory and perioperative hemoglobin decrease were associated with postoperative outcomes after major abdominal surgery. Methods: We performed a secondary analysis of the international POSTVenTT cohort, a prospective multicentre observational study of adults undergoing major abdominal surgery. Hemoglobin trajectory was defined according to anemia status preoperatively and at hospital discharge. Perioperative hemoglobin decrease was defined as the difference between preoperative and discharge hemoglobin concentration. Mixed‐effects logistic regression models adjusted for predefined clinical covariates and center clustering were used to evaluate associations with postoperative complications, postoperative transfusion, and 30‐day readmission. Results: Among 5302 patients, 3735 had both preoperative and discharge hemoglobin measurements and were included in trajectory analyses. Compared with patients without perioperative anemia, persistent anemia was associated with the higher odds of postoperative complications, postoperative transfusion, and 30‐day readmission, whereas new postoperative anemia showed similar but smaller associations. Greater perioperative hemoglobin decrease was associated with higher odds of postoperative complications. For each 10 g/L decrease, the odds of any postoperative complication increased by 35% (OR 1.35, 95% CI 1.26–1.45) and major complication by 49% (OR 1.49, 1.35–1.64). Associations persisted after accounting for transfusion exposure and baseline hemoglobin. Conclusions: Perioperative hemoglobin trajectory and perioperative hemoglobin decrease were associated with postoperative complications and 30‐day readmission after major abdominal surgery. Greater hemoglobin decrease remained associated with adverse outcomes after accounting for transfusion exposure and baseline hemoglobin. Trial Registration: The POSTVenTT study was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12621001517864; 8 November 2021). The trial protocol was approved by the South Metropolitan Health Service (Western Australia) Health Research Ethics Committee (EC00265), the Western Australia Research Governance System (RCG 4477), with local ethics and governance confirmed at each site before patient recruitment
- 6 July 2026
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 75, 103437
Preoperative nutritional risk predicts postoperative complications but not delirium: evidence from a multicentre surgical cohort
- 6 July 2026
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 75, 103437
Preoperative nutritional risk predicts postoperative complications but not delirium: evidence from a multicentre surgical cohort